A Perioperative Sintilimab and Chemotherapy in Esophageal Squamous Cell Carcinoma
Status:
Not yet recruiting
Trial end date:
2027-12-15
Target enrollment:
Participant gender:
Summary
This study is aimed to evaluate the efficacy and safety of sintilimab combined with
chemotherapy versus chemotherapy in perioperative treatment of locally advanced esophageal
squamous cell carcinoma.